These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 846677)

  • 81. Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients.
    Tan SA; Berk LS; Tan LG
    Am J Cardiol; 1996 Feb; 77(6):20B-22B. PubMed ID: 8848989
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of indapamide on phosphate metabolism and vascular reactivity.
    Plante GE; Lafreniere MC; Tam PT; Sirois P
    Am J Med; 1988 Jan; 84(1B):26-30. PubMed ID: 3277416
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Nadolol in combination with indapamide and xipamide in resistant hypertensives.
    Dean S; Kendall MJ; Potter S; Thompson MH; Jackson DA
    Eur J Clin Pharmacol; 1985; 28(1):29-33. PubMed ID: 3987783
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of indapamide on left ventricular mass and function in systemic hypertension with left ventricular hypertrophy.
    Komajda M; Klimczak K; Boutin B; Brackman F; Guez D; Grosgogeat Y
    Am J Cardiol; 1990 May; 65(17):37H-42H. PubMed ID: 2139541
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure.
    Peng J; Zhao Y; Zhang H; Liu Z; Wang Z; Tang M; Zhong M; Lu F; Zhang W
    Hypertens Res; 2015 Feb; 38(2):123-31. PubMed ID: 25273554
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hypertension in diabetic patients--an evaluation of indapamide treatment.
    Bam WJ; Bouwer C
    S Afr Med J; 1983 May; 63(21):802-3. PubMed ID: 6342172
    [No Abstract]   [Full Text] [Related]  

  • 87. Effect of indapamide on serum and red cell cations, with and without magnesium supplementation, in subjects with mild hypertension.
    Taylor DR; Constable J; Sonnekus M; Milne FJ
    S Afr Med J; 1988 Sep; 74(6):273-6. PubMed ID: 3047887
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Indapamide: a unique diuretic?
    Conner CS
    Drug Intell Clin Pharm; 1983 Dec; 17(12):898-9. PubMed ID: 6653405
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Therapeutic monitoring of metipamide during antihypertensive therapy.
    Klíma J; Grafnetterová J; Kubelka Z; Klíma J
    J Chromatogr; 1989 Mar; 488(1):295-300. PubMed ID: 2715287
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical positioning of indapamide sustained release 1.5mg in management protocols for hypertension.
    Leonetti G
    Drugs; 2000; 59 Suppl 2():27-38; discussion 39-40. PubMed ID: 10678595
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Extrarenal contributions to indapamide's antihypertensive mechanism of action.
    Noveck RJ; McMahon FG; Quiros A; Giles T
    Am Heart J; 1983 Jul; 106(1 Pt 2):221-9. PubMed ID: 6869204
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Long-term effectiveness of indapamide in hypertension: neural, renin and metabolic responses.
    de Ortiz H; DeQuattro E; Stephanian E; DeQuattro V
    Clin Exp Hypertens A; 1983; 5(5):665-72. PubMed ID: 6349866
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Significant hypertrophy regression with indapamide sustained release 1.5 mg.
    Cardiovasc J S Afr; 2001; 12(1):52-3. PubMed ID: 11474686
    [No Abstract]   [Full Text] [Related]  

  • 94. [Antihypertensive effect of indapamide and its effect on extracellular and intracellular Na and K concentrations in red blood cells].
    Du FH; Wang Q
    Zhonghua Nei Ke Za Zhi; 1985 Dec; 24(12):705-8, 767. PubMed ID: 3830615
    [No Abstract]   [Full Text] [Related]  

  • 95. Pharmacological properties of indapamide. Rationale for use in hypertension.
    Bataillard A; Schiavi P; Sassard J
    Clin Pharmacokinet; 1999; 37 Suppl 1():7-12. PubMed ID: 10491728
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension.
    Ohta Y; Kamide K; Hanada H; Morimoto S; Nakahashi T; Takiuchi S; Ishimitsu T; Tsuchihashi T; Soma M; Tomohiro Katsuya T; Sugimoto K; Rakugi H; Oukura T; Higaki J; Matsuura H; Shinagawa T; Miwa Y; Sasaguri T; Igase M; Miki T; Takeda K; Higashiura K; Shimamoto K; Katabuchi R; Ueno M; Hosomi N; Kato J; Komai N; Kojima S; Sase K; Iwashima Y; Yoshihara F; Horio T; Nakamura S; Nakahama H; Miyata T; Kawano Y
    Hypertens Res; 2020 Mar; 43(3):220-226. PubMed ID: 31748705
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis.
    Carey PA; Sheridan DJ; de Cordoue A; Guez D
    Am J Cardiol; 1996 Feb; 77(6):17b-19b. PubMed ID: 8848988
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The place of indapamide in the treatment of arterial hypertension.
    Thénot A
    Curr Med Res Opin; 1983; 8 Suppl 3():140-4. PubMed ID: 6617238
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Tolerability and efficacy of retard form of indapamide in the treatment of hypertension in elderly patients (results of multicenter open non-comparative trial in Russian program ARGUS)].
    Kobalava ZhD; Kotovskaia IuV; Vereshchagina GN; Luk'ianchikova VF; Nekrutenko LA; Nechaeva GI; Sklizkova LA; Slobodianiuk AL; Filippenko NG; Shlyk SV; Maksimenko VV; Moiseev VS
    Kardiologiia; 2002; 42(7):25-35. PubMed ID: 12494109
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Efficacy of indapamide in central diabetes insipidus.
    Tetiker T; Sert M; Koçak M
    Arch Intern Med; 1999 Sep; 159(17):2085-7. PubMed ID: 10510995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.